Seminar Series

  seminarseries

The T32 Program hosts monthly seminars for trainees, affiliate postdocs, and members of the participating institutions and labs on a variety of topics, from basic science, to entrepreneurship and translation.

If you would like to attend the seminars (they are hosted remotely) or give a seminar to this engaged group of scientists, please contact program manager Suzanne Squires at This email address is being protected from spambots. You need JavaScript enabled to view it.

The 2018-2019 seminar series schedule is below, which highlights the diversity of topics covered:

  • October 18, 2018 – Scott Wadsworth, PhD, PMP - Director of Pharmaceutical Development at Envigo “How to plan a preclinical safety program to support an IND for a small molecule drug”
  • December 13, 2018 - Leonard Lee, MD, Professor of Surgery, James W. Mackenzie, M.D. Endowed Chair in Surgery, Chair Department of Surgery Rutgers Robert Wood Johnson Medical School 
  • January 10, 2019 - Richard Clark, MD Professor and Vice Chair for Research, Dermatology Stony Brook University; Founder, Neomatrix Therapeutics “Commercialization pathways in regenerative medicine”
  • February 14, 2019 - Charles Gatt Associate Professor and Chairman of Orthopaedic Surgery “A Tissue Engineered Meniscus- Bench Top to Clinic”
  • April 25, 2019 - Richard Marfuggi MD FACS DMH, Visiting Teaching Professor and RCR instructor for the T32 program “Responsible Conduct of Research: Ethics of Animal Experimentation”
  • May 16, 2019 - Jennifer Walsh, Director of Sustaining Engineering, Medtronic  “Project Management 101”
  • May 30, 2019 - Richard Marfuggi MD FACS DMH, Visiting Teaching Professor and RCR instructor for the T32 Program, and Steve Brozak, Managing Partner and President of WBB Securities “Responsible Conduct of Research: Informed Consent and Realities of Advancing Clinical Therapeutics in the Marketplace”
  • August 29, 2019 – Richard Clark MD Professor and Vice Chair for Research, Dermatology Stony Brook University; Founder, Neomatrix Therapeutics “Long road to commercialization of a fibronectin-derived, multi-functional peptide for treatment of burns, wounds, and other inflammatory conditions”
  • October 24, 2019 – Richard Marfuggi MD FACS DMH, Visiting Teaching Professor and RCR instructor for the T32 Program, “Responsible Conduct of Research: Ethics of Informed Consent”
  • November 14, 2019 – Chand Sishta PhD, RAC, Bespoke Pharmaceutical Consulting Services, LLC “A Small Task – The Future of Translational Medicine”